See also this year's filing and all EDGAR filings for this company.
PDF Report 0001311596_2014_Tobira_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 832000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001311596, Tobira Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 39,128,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 108,000 |
| 3 | remainder_Assets | 6,517,000 |
| 4 | LiabilitiesCurrent | 9,100,000 |
| 5 | LiabilitiesNoncurrent | 2,452,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,297,000 |
| 9 | ResearchAndDevelopmentExpense | 26,542,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 832,000 |
| 12 | remainder_NetIncome | -600,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 45,753,000 |
| 1 | Liabilities | 11,552,000 |
| 2 | Expenses | 33,839,000 |
| 3 | Revenues | 832,000 |
| 4 | StockholdersEquity | 34,201,000 |
| 5 | NetIncome | -33,607,000 |
| 6 | ComprehensiveNetIncome | -33,607,000 |
| 7 | BaseVar | 46,288,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.43 |
| 9 | EconomicCapitalRatio | 2.63 |